Internet Archive Scholar

The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: A systematic review and Meta-analysis [report]

Yushuai Yu, Jie Zhang, Kaiyan Huang, Yuxiang Lin, Chuangui Song
2021 unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (80.2 kB)
https://web.archive.org/web/20220519052111/https://inplasy.com/wp-content/uploads/2021/07/INPLASY-Protocol-2002.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Review question / Objective: We conducted this meta-analysis to explore the efficacy and safety of Tyrosine kinase inhibitors (TKIs) compared with non-TKIs regimens in HER-2 positive breast cancer with brain metastases. Condition being studied: The survival of breast cancer brain metastasis (BCBM) patients is extremely poor. The cornerstone INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols
doi:10.37766/inplasy2021.7.0064 fatcat:wdzppmlhkbfntnqkkhrznfwbsu
Citation

Yushuai Yu, Jie Zhang, Kaiyan Huang, Yuxiang Lin, Chuangui Song. "The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: A systematic review and Meta-analysis." (2021)